Results: HLN

Search articles by EPIC code
EPIC HLN
views

Is it double or quits time for Haleon shareholders?

As I observed yesterday, “some GSK plc (GSK) shareholders have sold their Haleon (HLN) spin-off shares and some have not”. I belong in the latter group on the basis that yesterday’s half one numbers are a classic double or quits moment. After having the opportunity to listen to the conference call yesterday, what am I going to do with my position in one of the world's largest consumer health brands businesses given the range of oral health, vitamins, minerals and supplements (VMS), pain relief and digestive health product exposures the company has.

Page 1 of 1 (2 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments